BARCLAYS PLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 312069 LONDON, X0

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,104,787

-$1,464,897 QoQ

Shares Held

1,630,659

-42.0% QoQ

Ownership

0.500%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#35

of 208 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. TSHA ranks #26 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,104,787	1,630,659	-42.0%	Shares	Defined	2026-08-14
2026-03-31	$12,569,684	2,812,010	-49.2%	Shares	Defined	2026-05-15
2025-12-31	$30,464,505	5,539,001	+7.6%	Shares	Sole	2026-02-13
2025-09-30	$16,834,326	5,148,112	+1042.8%	Shares	Sole	2026-03-31
2025-06-30	$1,040,657	450,501	-36.5%	Shares	Sole	2026-02-27
2025-03-31	$985,462	708,966	+111.5%	Shares	Sole	2026-03-17
2024-12-31	$579,961	335,238	+35.6%	Shares	Sole	2026-03-19
2024-09-30	$497,032	247,280	+356.0%	Shares	Sole	2026-03-31
2024-06-30	$121,484	54,234	+23.2%	Shares	Sole	2026-03-23
2022-12-31	$99,469	44,013	-8.1%	Shares	Sole	2026-03-30
2022-09-30	$92,406	47,879	0.0%	Shares	Sole	2022-11-03
2022-06-30	$178,109	47,879	+7.9%	Shares	Sole	2022-08-12
2022-03-31	$289,403	44,387	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.